AMB-05X
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AmMax Bio, Inc.
Overview
AMB-05X is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AMB-05X clinical trials
Explore related
Medical disclaimer. This page summarizes research about AMB-05X for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.